期刊文献+

非小细胞肺癌患者贫血相关因素及其对预后的影响 被引量:4

Correlative factors of anemia in patients with non-small-cell lung cancer and the impact of anemia on prognosis
原文传递
导出
摘要 目的分析非小细胞肺癌(NSCLC)患者贫血发生的相关因素及其对预后的影响。方法回顾性分析河北医科大学附属第四医院2008年1月至2012年11月收治的首次住院的473例NSCLC患者的临床资料。结果473例NSCLC患者中,贫血患者共273例,贫血发生率为57.72%;贫血发生率在不同年龄(χ2=3.459,P=0.039)、清蛋白水平(χ2=70.648,P=0.000)、功能状态(PS)评分(χ2=10.222,P=0.010)、近期是否行手术(χ2=4.956,P=0.022)及近期是否化疗(χ2=3.627,P=0.037)等因素中差异均有统计学意义。经多因素分析,低蛋白血症是贫血发生的独立危险因素(P〈0.05)。贫血组的总生存时间短于非贫血组(中位数分别为15、17个月,P〈0.05)。结论低蛋白血症是NSCLC患者贫血发生的独立危险因素。贫血的出现是NSCLC患者生存期缩短的预后指标,是NSCLC患者预后的独立因素。 Objective To analyze the correlative factors of anemia in patients with non-small-cell lung cancer (NSCLC), and to explore the impact of anemia on prognosis. Methods The clinical data of 473 patients with NSCLC treated at the first time from January 2008 to November 2012 in the Fourth Hospital of Hebei Medical University were analyzed retrospectively. Results There were 273 patients (57.72 %) with anemia. Anemia occurred in different age (χ2 = 3.459, P = 3.459), different albumin level (χ2 = 70.648, P = 70.648), different PS score (χ2 = 10.222, P = 10.222), whether recent surgery (χ2 = 4.956, P = 4.956), whether recent chemotherapy (χ2 = 3.627, P = 0.037), and other factors. By multiple factors analysis, hypoalbuminemia was an independent risk factor for anemia (P 〈 0.05). The median OS of the anemia patients was shorter than that of the patients without anemia (15 months vs 17 months, P 〈 0.05). Conclusions Hypoalbuminemia is the independent risk factor for emergence of anemia. Anemia is the prognosis indicator of shorten survival period, which is an independent factor of prognosis in the NSCLC.
出处 《肿瘤研究与临床》 CAS 2015年第10期687-689,693,共4页 Cancer Research and Clinic
关键词 非小细胞肺 贫血 相关因素 预后 Cancer, non-small-cell lung Anemia Related factors Prognosis
  • 相关文献

参考文献18

  • 1CSCO肿瘤相关性贫血专家委员会肿瘤相关性贫血临床实践指南2012.2013版[R/OL].http://csc02012.medlive.ccms/show-ztbd.394.html.
  • 2魏沙.2002-2010年我国城市恶性肿瘤死亡率变化趋势分析[J].实用预防医学,2013,20(1):111-113. 被引量:52
  • 3Ludwig H, van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS):a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients [J]. Eur J Cancer, 2004, 40 ( 15 ) : 2293-2306.
  • 4王杰军.2012年中国肿瘤贫血现状百家医院调研结果发布报告[R/OL].http://csc02012.medlive.cn/cms/how-ppt-351.html.
  • 5Pirker R, Pirolli M, Quigley J, et al. Hemoglobin decline in cancer patients receiving chemotherapy without an agent [J]. Support Care Cancer, 2013, 21 ( 4 ) : 987-992.
  • 6Gasen P, Almentrez J, Artal fit, et al. Management of lung cancer- associated anaemia: the Spanish Lung Cancer Anaemia Survey ( SLCAS ) [J]. Clin Transl Oncol, 2011, 13 ( 5 ) : 328-334.
  • 7刘彤华.肿瘤相关性贫血相关因素分析[J].中国实验诊断学,2013,17(9):1688-1691. 被引量:26
  • 8Aapro M, 0sterborg A, Gascn P, et al. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron[J]. Ann Oncol, 2012, 23 ( 8 ) : 1954-1962.
  • 9Link H, Schmitz S. Treatment of cancer-associated anaemia: results from a two-day cross-sectional survey in Germany [J]. Onkologie, 2013, 36(5) : 266-272.
  • 10Wasada I, Eguehi H, Kurita M, et al. Anemia affects the quality of life of Japanese cancer patients [J]. Tokai J Exp Clin Med, 2013, 38 (1):7-11.

二级参考文献62

共引文献118

同被引文献66

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部